✦ LIBER ✦

The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker

✍ Scribed by Salmans, Michael L; Zhao, Fang; Andersen, Bogi

Book ID: 120999961
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 757 KB
Volume: 15
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The docking protein Gab2 is overexpresse

The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer

✍ Daly, Roger J; Gu, Haihua; Parmar, Jayamala; Malaney, Suzann; Lyons, Ruth J; Kai 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 337 KB

P227: Anterior gradient 2 and TFF1 coexp

P227: Anterior gradient 2 and TFF1 coexpression in breast cancer lymph node metastases from estrogen receptor-negative (ER-) primary tumors contributes to the metastatic phenotype

✍ P. Davoodi; A. Graham; K. Mikhitarian; M. Mitas; D.J. Cole 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Modulation of the estrogen-regulated pro

Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems

✍ Simone Panagiotou; Anastassia Hatzoglou; Fabien Calvo; Pierre-Marie Martin; Elia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 3 views

In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-